Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population

Experimental Dermatology

Volumn 15, Issue 5, 2006, Pages 377-380

  Park, Hyun Ho ^a   Ha, Eunyoung ^a   Uhm, Yoon Kyung ^a   Jin, Sheng Yu ^a   Kim, Youn Jung ^b   Chung, Joo Ho ^a   Lee, Mu Hyoung ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Association; Catalase; Polymorphism; RFLP; Vitiligo

Indexed keywords

CATALASE; CYTOSINE; THYMINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO; VOLUNTEER; CASE CONTROL STUDY; ENZYMOLOGY; GENETICS;

ADULT; CASE-CONTROL STUDIES; CATALASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KOREA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; VITILIGO;

EID: 33745238389     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2006.00423.x     Document Type: Article

References (26)

1. Kovacs S O. Vitiligo. J Am Acad Dermatol 1998: 38: 647-666.
2. Lerner A. On the etiology of vitiligo and gray hair. Am J Med 1971: 51: 141-147.
3. Schallreuter K U, Wood J M, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991: 97: 1081-1085.
4. Schallreuter K U, Moore J, Wood J M et al. Epidermal H(2)O(2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes? J Invest Dermatol 2001: 116: 167-174.
5. Schallreuter K U, Moore J, Wood J M et al. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 1999: 4: 91-96.
6. Schallreuter K U, Moore J, Behrens-Williams S, Panske A, Harari M. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol 2002: 41: 482-487.
7. Behl P N, Bhathia R K. 400 cases of vitiligo: A clinicotherapeutic analysis. Indian J Dermatol 1972: 17: 51-55.
8. Koranne R V, Sachdeva K G. Vitiligo. Int J Dermatol 1988: 27: 676-681.
9. Majumder P P, Das S K, Li C C. A genetic model for vitiligo. Am J Hum Genet 1988: 43: 119-125.
10. Majumder P P, Nordlund J J, Nath S K. Pattern of familial aggregation of vitiligo. Arch Dermatol 1993: 129: 994-998.
11. Casp C B, She J X, McCormack W T. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002: 15: 62-66.
12. Kemp E H, Ajjan R A, Waterman E A et al. Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo. Br J Dermatol 1999: 140: 73-78.
13. Schallreuter K U, Blau N. GTP-cyclohydrolase and vitiligo. Lancet 1997: 350: 1254.
14. Arcos-Burgos M, Parodi E, Salgar M et al. Vitiligo: Complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum Genet 2002: 110: 334-342.
15. Tursen U, Kaya T I, Erdal M E, Derici E, Gunduz O, Ikizoglu G. Association between catechol-O-methyltransferase polymorphism and vitiligo. Arch Dermatol Res 2002: 294: 143-146.
16. Nath S K, Kelly J A, Namjou B et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 2001: 69: 1401-1406.
17. Le Poole I C, Sarangarajan R, Zhao Y et al. 'VIT1', a novel gene associated with vitiligo. Pigment Cell Res 2001: 14: 475-484.
18. Jin S Y, Park H H, Li G Z et al. Association of angiotensin converting enzyme gene I/D polymorphism of vitiligo in Korean population. Pigment Cell Res 2004: 17: 84-86.
19. Terwilliger J D, Ott J. Linkage disequilibrium between alleles at marker loci. In: Handbook of Human Genetic Linkage, 1st edn. Johns Hopkins University Press: Baltimore, 1994: 188-198.
20. Maresca V, Roccella M, Roccella F et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997: 109: 310-313.
21. Picardo M, Passi S, Morrone A, Grandinetti M, Di Carlo A, Ippolito F. Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 1994: 7: 110-111.
22. Beazley W D, Gaze D, Panske A, Panzig E, Schallreuter K U. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 1999: 141: 301-303.
23. Kurzen H, Schallreuter K U. Novel aspects in cutaneous biology of acetylcholine synthesis and acetylcholine receptors. Exp Dermatol 2004: 13 (Suppl. 4): 27-30.
24. Goth L, Vitai M. Polymorphism of 5′ of the catalase gene in Hungarian acatalasemia and hypocatalasemia. Electrophoresis 1997: 18: 1105-1108.
25. Ukkola O, Erkkila P H, Savolainen M J, Kesaniemi Y A. Lack of association between polymorphisms of catalase, copper-zinc superoxide (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med 2001: 249: 451-459.
26. Park J K, Lee H J, Bahn G H. The association between Korean schizophrenics and catalase gene polymorphism. J Korean Soc Biol Psychiatry 2002: 9: 21-25.